Presymptomatic Identification of CDH1 Germline Mutation in a Healthy Korean Individual with Family History of Gastric Cancer
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Gastric cancer (GC) is one of the most common cancers with high morbidity and mortality. Familial GC is seen in 10% of cases, and approximately 3% of familial GC cases arise ow- ing to hereditary diffuse gastric cancer (HDGC). CDH1 , which encodes the protein E-cad- herin, is the only gene whose mutations are associated with HDGC. Screening for the fa- milial GC-predisposing gene has been neglected in high-risk countries such as Korea, China, and Japan, where all the cases have been attributed to Helicobacter pylori or other carcinogens. Screening for the GC-causing CDH1 mutation may provide valuable informa- tion for genetic counseling, testing, and risk-reduction management for the as-yet unaf- fected family members. An asymptomatic 44-yr-old Korean male visited our genetic clinic for consultation owing to his family history of GC. Eventually, c.1018A>G in CDH1 , a known disease-causing mutation, was found. As of the publication time, the individual is alive without the evidence of GC, and is on surveillance. To our knowledge, this is the first Korean case of presymptomatic detection of CDH1 mutation, and it highlights the impor- tance of genetic screening for individuals with a family history of GC, especially in high-risk geographical areas.
Abstract
Gastric cancer (GC) is one of the most common cancers with high morbidity and mortality. Familial GC is seen in 10% of cases, and approximately 3% of familial GC cases arise ow- ing to hereditary diffuse gastric cancer (HDGC). CDH1 , which encodes the protein E-cad- herin, is the only gene whose mutations are associated with HDGC. Screening for the fa- milial GC-predisposing gene has been neglected in high-risk countries such as Korea, China, and Japan, where all the cases have been attributed to Helicobacter pylori or other carcinogens. Screening for the GC-causing CDH1 mutation may provide valuable informa- tion for genetic counseling, testing, and risk-reduction management for the as-yet unaf- fected family members. An asymptomatic 44-yr-old Korean male visited our genetic clinic for consultation owing to his family history of GC. Eventually, c.1018A>G in CDH1 , a known disease-causing mutation, was found. As of the publication time, the individual is alive without the evidence of GC, and is on surveillance. To our knowledge, this is the first Korean case of presymptomatic detection of CDH1 mutation, and it highlights the impor- tance of genetic screening for individuals with a family history of GC, especially in high-risk geographical areas.
참고문헌 (20)
- Vogelaar IP, "Familial gastric cancer: detection of a hereditary cause helps to understand its etiology", Hered Cancer Clin Pract, 10, pp.18~ (2012)
- 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2013", Cancer Research and Treatment, 45(1), pp.15~21 (2013), 대한암학회
- 최일주, "위암의 스크리닝 및 진단", 대한소화기학회지, 54(2), pp.67~76 (2009), 대한소화기학회
- Aesun Shin, "Gastric Cancer Epidemiology in Korea", Journal of Gastric Cancer, 11(3), pp.135~140 (2011), 대한위암학회
- Fujita H, "Endoscopic surveillance of patients with hereditary diffuse gastric cancer: biopsy recommendations after topographic distribution of cancer foci in a series of 10 CDH1-mutated gastrectomies", Am J Surg Pathol, 36, pp.1709~1717 (2012)
- Hu B, "Gastric cancer: Classification, histology and application of molecular pathology", J Gastrointest Oncol, 3, pp.251~261 (2012)
- Fitzgerald RC, "Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research", J Med Genet, 47, pp.436~444 (2010)
- Oliveira C, "Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred", Hum Mutat, 19, pp.510~517 (2002)
- Corso G, "Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature", BMC Cancer, 12, pp.8~ (2012)
- Pharoah PD, "Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families", Gastroenterology, 121, pp.1348~1353 (2001)
- Kaurah P, "Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer", JAMA, 297, pp.2360~2372 (2007)
- Zhang Y, "Germline mutations and polymorphic variants in MMR, E-cadherin and MYH genes associated with familial gastric cancer in Jiangsu of China", Int J Cancer, 119, pp.2592~2596 (2006)
- Kim HC, "The E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea", Gut, 47, pp.262~267 (2000)
- Suriano G, "E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells", Hum Mol Genet, 12, pp.3007~3016 (2003)
- More H, "Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene", Hum Mutat, 28, pp.203~ (2007)
- Hamilton LE, "Synchronous appendiceal and intramucosal gastric signet ring cell carcinomas in an individual with CDH1-associated hereditary diffuse gastric carcinoma: a case report of a novel association and review of the literature", BMC Gastroenterol, 13, pp.114~ (2013)
- Blair V, "Hereditary diffuse gastric cancer: diagnosis and management", Clin Gastroenterol Hepatol, 4, pp.262~275 (2006)
- Chen Y, "A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer", Ann Surg Oncol, 18, pp.2594~2598 (2011)
- Kim S, "Searching for E-cadherin gene mutations in early onset diffuse gastric cancer and hereditary diffuse gastric cancer in Korean patients", FAMILIAL CANCER, 12, pp.503~507 (2013), Springer
- Sollip Kim, "Novel mechanism of a CDH1 splicing mutation in a Korean patient with signet ring cell carcinoma", BMB Reports, 44(11), pp.725~729 (2011), 생화학분자생물학회